{
 "url": "https://etfiq.com/funds/fbt/holdings/",
 "section": "funds",
 "title": "FBT Holdings: All 30 Positions (Oct 13, 2026) | ETFIQ",
 "description": "All 30 FBT holdings with weights, as of Oct 13, 2026. The top 3 are NTRA 4.69%, HALO 4.60% and ILMN 4.56%. Download the full list as a CSV.",
 "as_of": "Oct 13, 2026",
 "ticker": "FBT",
 "fund": "First Trust NYSE Arca Biotechnology Index Fund",
 "fund_page": "https://etfiq.com/funds/fbt",
 "positions": 30,
 "positions_listed_on_page": 30,
 "lead": "FBT held 30 positions as of Oct 13, 2026. Natera, Inc. is the largest at 4.69%; the top 10 are 40.7% of the fund.",
 "source": {
  "name": "First Trust",
  "url": "https://www.ftportfolios.com/Retail/Etf/EtfHoldings.aspx?Ticker=FBT",
  "document": "the issuer’s own daily file",
  "book_date": "2026-10-13",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Natera, Inc.",
   "ticker": "NTRA",
   "weight_pct": 4.69,
   "page": "https://etfiq.com/holdings/ntra/"
  },
  {
   "rank": 2,
   "holding": "Halozyme Therapeutics, Inc.",
   "ticker": "HALO",
   "weight_pct": 4.6,
   "page": "https://etfiq.com/holdings/halo/"
  },
  {
   "rank": 3,
   "holding": "Illumina, Inc.",
   "ticker": "ILMN",
   "weight_pct": 4.56,
   "page": "https://etfiq.com/holdings/ilmn/"
  },
  {
   "rank": 4,
   "holding": "Corcept Therapeutics Inc.",
   "ticker": "CORT",
   "weight_pct": 4.1,
   "page": "https://etfiq.com/holdings/cort/"
  },
  {
   "rank": 5,
   "holding": "Genmab A/S (ADR)",
   "ticker": "GMAB",
   "weight_pct": 4.03,
   "page": "https://etfiq.com/holdings/gmab/"
  },
  {
   "rank": 6,
   "holding": "Repligen Corporation",
   "ticker": "RGEN",
   "weight_pct": 3.89,
   "page": "https://etfiq.com/holdings/rgen/"
  },
  {
   "rank": 7,
   "holding": "NeoGenomics, Inc.",
   "ticker": "NEO",
   "weight_pct": 3.78,
   "page": "https://etfiq.com/holdings/neo/"
  },
  {
   "rank": 8,
   "holding": "BeOne Medicines Ltd. (ADR)",
   "ticker": "ONC",
   "weight_pct": 3.74,
   "page": "https://etfiq.com/holdings/onc/"
  },
  {
   "rank": 9,
   "holding": "Biogen Inc.",
   "ticker": "BIIB",
   "weight_pct": 3.68,
   "page": "https://etfiq.com/holdings/biib/"
  },
  {
   "rank": 10,
   "holding": "Gilead Sciences, Inc.",
   "ticker": "GILD",
   "weight_pct": 3.64,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 11,
   "holding": "ADMA Biologics, Inc.",
   "ticker": "ADMA",
   "weight_pct": 3.63,
   "page": "https://etfiq.com/holdings/adma/"
  },
  {
   "rank": 12,
   "holding": "Amgen Inc.",
   "ticker": "AMGN",
   "weight_pct": 3.63,
   "page": "https://etfiq.com/holdings/amgn/"
  },
  {
   "rank": 13,
   "holding": "Regeneron Pharmaceuticals, Inc.",
   "ticker": "REGN",
   "weight_pct": 3.63,
   "page": "https://etfiq.com/holdings/regn/"
  },
  {
   "rank": 14,
   "holding": "Exelixis, Inc.",
   "ticker": "EXEL",
   "weight_pct": 3.37,
   "page": "https://etfiq.com/holdings/exel/"
  },
  {
   "rank": 15,
   "holding": "Bio-Techne Corporation",
   "ticker": "TECH",
   "weight_pct": 3.25,
   "page": "https://etfiq.com/holdings/tech/"
  },
  {
   "rank": 16,
   "holding": "Vertex Pharmaceuticals Incorporated",
   "ticker": "VRTX",
   "weight_pct": 3.2,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 17,
   "holding": "United Therapeutics Corporation",
   "ticker": "UTHR",
   "weight_pct": 3.18,
   "page": "https://etfiq.com/holdings/uthr/"
  },
  {
   "rank": 18,
   "holding": "BioNTech SE (ADR)",
   "ticker": "BNTX",
   "weight_pct": 3.11,
   "page": null
  },
  {
   "rank": 19,
   "holding": "TG Therapeutics, Inc.",
   "ticker": "TGTX",
   "weight_pct": 3.04,
   "page": "https://etfiq.com/holdings/tgtx/"
  },
  {
   "rank": 20,
   "holding": "Bruker Corporation",
   "ticker": "BRKR",
   "weight_pct": 2.99,
   "page": "https://etfiq.com/holdings/brkr/"
  },
  {
   "rank": 21,
   "holding": "Incyte Corporation",
   "ticker": "INCY",
   "weight_pct": 2.98,
   "page": "https://etfiq.com/holdings/incy/"
  },
  {
   "rank": 22,
   "holding": "BioMarin Pharmaceutical Inc.",
   "ticker": "BMRN",
   "weight_pct": 2.94,
   "page": "https://etfiq.com/holdings/bmrn/"
  },
  {
   "rank": 23,
   "holding": "argenx SE (ADR)",
   "ticker": "ARGX",
   "weight_pct": 2.93,
   "page": "https://etfiq.com/holdings/argx/"
  },
  {
   "rank": 24,
   "holding": "Sarepta Therapeutics, Inc.",
   "ticker": "SRPT",
   "weight_pct": 2.79,
   "page": "https://etfiq.com/holdings/srpt/"
  },
  {
   "rank": 25,
   "holding": "Madrigal Pharmaceuticals, Inc.",
   "ticker": "MDGL",
   "weight_pct": 2.69,
   "page": "https://etfiq.com/holdings/mdgl/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "US Dollar",
   "weight_pct": 0.08
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/fbt/holdings/fbt-holdings.csv",
 "json_book": "https://etfiq.com/data/books/fbt.json",
 "markdown": "https://etfiq.com/funds/fbt/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of FBT, data as of Oct 13, 2026. https://etfiq.com/funds/fbt/holdings/"
}